Study Details

Back to Search Results

A study to find the best dose of ASP5354 to show lymph nodes in people with breast cancer or melanoma during surgery

This trial is recruiting
The study is currently recruiting participants.

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT05457842

Astellas Study ID

The unique identification code given by the study sponsor.

5354-CL-1201

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Lymph Node Biopsy, Breast Cancer, Melanoma

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 Years - N/A

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Aug 2022 - Sep 2023

Masking

None (Open Label)

Enrollment number

132

A Phase 2 Open-label, Dose-finding Study to Determine the Optimal dose for Lymph Node Visualization using ASP5354 in Participants with Breast Cancer or Melanoma Undergoing Sentinel Lymph Node Biopsy

Study summary

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A study to find the best dose of ASP5354 to show lymph nodes in people with breast cancer or melanoma during surgery? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

UCI Irvine Health-Chao Family Comprehensive Cancer Center Cancer

Orange, United States, 92868

Recruiting
Contact Us

The University of Texas MD Anderson Cancer Center

Houston, United States, 77030

Recruiting
Contact Us

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo